<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2024-4-769-776</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2502</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORT</subject></subj-group></article-categories><title-group><article-title>Сыворотка крови в лечении эпителиопатии различного генеза. Клинические наблюдения</article-title><trans-title-group xml:lang="en"><trans-title>Blood Serum in the Treatment of Epitheliopathy of Various Genesis. Clinical Observations</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8594-2395</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каспарова</surname><given-names>Е. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Kasparova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каспарова Евгения Аркадьевна, кандидат медицинских наук, ведущий научный сотрудник отдела патологии оптических сред глаза</p><p>ул. Россолимо, 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Kasparova Evgeniya A., PhD, leading research officer of the Optical media of the eye pathology department</p><p>Rossolimo str., 11A. B, Moscow, 119021</p></bio><email xlink:type="simple">kasparova_jane@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6974-7872</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Криволапова</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Krivolapova</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Криволапова Диана Алексеевна, аспирант</p><p>ул. Россолимо, 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Krivolapova Diana A., postgraduate</p><p>Rossolimo str., 11A. B, Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней им. М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>24</day><month>12</month><year>2024</year></pub-date><volume>21</volume><issue>4</issue><fpage>769</fpage><lpage>776</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каспарова Е.A., Криволапова Д.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Каспарова Е.A., Криволапова Д.А.</copyright-holder><copyright-holder xml:lang="en">Kasparova E.A., Krivolapova D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2502">https://www.ophthalmojournal.com/opht/article/view/2502</self-uri><abstract><p>В статье рассматриваются результаты применения сыворотки крови в лечении эпителиопатии различного генеза. Представлены 3 клинических случая, каждый из которых сопровождался эпителиопатией: нейротрофический кератит (I стадия), акантамебный кератит (I cтадия), а также эпителиопатия, развившаяся вследствие токсико-аллергической реакции. При эпителиопатии на фоне акантамебного кератита и токсико-аллергической реакции, помимо этиопатогенетической терапии, в качестве адъювантного лечения использовали инстилляции аутологичной сыворотки. При нейротрофической кератопатии аутологичную сыворотку применяли в качестве самостоятельного этиопатогенетического лечения. Сыворотка крови обладает нейропротекторным, регенеративным, противоинфекционным, противовоспалительным и слезозаместительным свойствами.</p></abstract><trans-abstract xml:lang="en"><p>The article reviews the results of the use of blood serum in the treatment of epitheliopathy of various genesis. Three clinical cases are presented, each of which was accompanied by epitheliopathy: neurotrophic keratitis (stage I), acanthamoebic keratitis (stage I), and epitheliopathy developed due to toxic-allergic reaction. In epitheliopathy on the background of acanthamoeba keratitis and toxic-allergic reaction, in addition to etiopathogenetic therapy, instillations of autologous serum were used as an adjuvant treatment. In neurotrophic keratopathy autologous serum was used as an independent etiopathogenetic treatment. The serum has neuroprotective, regenerative, anti-infective, anti-inflammatory and tear-replacement properties.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эпителиопатия</kwd><kwd>аутологичная сыворотка</kwd><kwd>сыворотка крови</kwd><kwd>нейротрофическая кератопатия</kwd><kwd>нейротрофический кератит</kwd><kwd>акантамебный кератит</kwd><kwd>токсическая эпителиопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>epitheliopathy</kwd><kwd>autologous serum</kwd><kwd>blood serum</kwd><kwd>neurotrophic keratopathy</kwd><kwd>neurotrophic keratitis</kwd><kwd>acanthamoeba keratitis</kwd><kwd>toxic epitheliopathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каспарова ЕА, Марченко НР. Нейротрофический кератит. Этиология, патогенез, клинические проявления. Обзор литературы. Часть 1. Офтальмология. 2022;19(1):38–45. doi: 10.18008/1816-5095-2022-1-38-45.</mixed-citation><mixed-citation xml:lang="en">Kasparova EA, Marchenko NR. Neurotrophic Keratitis. Etiology, Pathogenesis, Clinical Manifestations. Review. Part 1. Ophthalmology in Russia. 2022;19(1):38– 45. (In Russ.). doi: 10.18008/1816-5095-2022-1-38-45.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pflugfelder SC, Stern ME. The cornea in keratoconjunctivitis sicca. Exp Eye Res. 2020 Dec;201:108295. doi: 10.1016/j.exer.2020.108295. Epub 2020 Oct 7. PMID: 33038387; PMCID: PMC7736263.</mixed-citation><mixed-citation xml:lang="en">Pflugfelder SC, Stern ME. The cornea in keratoconjunctivitis sicca. Exp Eye Res. 2020 Dec;201:108295. doi: 10.1016/j.exer.2020.108295. Epub 2020 Oct 7. PMID: 33038387; PMCID: PMC7736263.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова ТН, Зайцева ГВ, Бурденный АМ. Полиморфные маркеры некоторых генов в развитии сухого кератоконъюнктивита у пациентов с ревматоидным артритом и синдромом Шегрена. Вестник офтальмологии. 2019;135(5):254–259. doi: 10.17116/oftal-ma2019135052254.</mixed-citation><mixed-citation xml:lang="en">Safonova TN, Zaitseva GV, Burdennyy AM. Polymorphic markers of certain genes in the development of dry keratoconjunctivitis in patients with rheumatoid arthritis and Sjogren’s syndrome. Russian Annals of Ophthalmology. 2019;135(5):254–259 (In Russ.). doi: 10.17116/oftal-ma2019135052254.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Каспаров АА. Офтальмогерпес. М.: Медицина, 1994. 83 с.</mixed-citation><mixed-citation xml:lang="en">Kasparov AA. Ophthalmoherpes. Moscow: Medicine, 1994. 83 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist. 2018 Jul 17;11:981–993. doi: 10.2147/IDR.S162669. PMID: 30046247; PMCID: PMC6054290.</mixed-citation><mixed-citation xml:lang="en">Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist. 2018 Jul 17;11:981–993. doi: 10.2147/IDR.S162669. PMID: 30046247; PMCID: PMC6054290.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Марченко НР, Каспарова ЕвгА. Диагностика акантамебного кератита. Вестник офтальмологии. 2016;132(5):103–109. doi: 10.17116/oftal-ma20161325103-109.</mixed-citation><mixed-citation xml:lang="en">Marchenko NR, Kasparova EvgA. Diagnosis of Acanthamoeba keratitis. Russian Annals of Ophthalmology. 2016;132(5):103–109 (In Russ.). doi: 10.17116/oftal-ma20161325103-109.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Марченко НР, Каспарова ЕвгА. Лечение акантамебного кератита. Вестник офтальмологии. 2016;132(5):110–116. doi: 10.17116/oftalma20161325110-116.</mixed-citation><mixed-citation xml:lang="en">Marchenko NR, Kasparova EvgA. Treatment of Acanthamoeba keratitis. Russian Annals of Ophthalmology. 2016;132(5):110–116 (In Russ.). doi: 10.17116/oftalma20161325110-116.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Coroi MC, Bungau S, Tit M. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE. Rom J Ophthalmol. 2015 JanMar;59(1):2–5. PMID: 27373107; PMCID: PMC5729814.</mixed-citation><mixed-citation xml:lang="en">Coroi MC, Bungau S, Tit M. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE. Rom J Ophthalmol. 2015 JanMar;59(1):2–5. PMID: 27373107; PMCID: PMC5729814.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication. Br J Ophthalmol. 2018 Nov;102(11):1497–1503. doi: 10.1136/bjophthalmol2017311544. Epub 2018 Jul 4. PMID: 29973365; PMCID: PMC6241623.</mixed-citation><mixed-citation xml:lang="en">Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication. Br J Ophthalmol. 2018 Nov;102(11):1497–1503. doi: 10.1136/bjophthalmol2017311544. Epub 2018 Jul 4. PMID: 29973365; PMCID: PMC6241623.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon CH, Lee HJ, Park HY, Kim H, Kim MK, Jeoung JW, Oh JY. Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by antiglaucoma drugs. Int Ophthalmol. 2020 Mar;40(3):547–552. doi: 10.1007/s10792-019-01211-8. Epub 2019 Nov 8. PMID: 31705358.</mixed-citation><mixed-citation xml:lang="en">Yoon CH, Lee HJ, Park HY, Kim H, Kim MK, Jeoung JW, Oh JY. Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by antiglaucoma drugs. Int Ophthalmol. 2020 Mar;40(3):547–552. doi: 10.1007/s10792-019-01211-8. Epub 2019 Nov 8. PMID: 31705358.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Трубилин ВН, Полунина ЕГ, Анджелова ДВ, Куренков ВВ, Капкова СГ, Чиненова КВ. Заболевания глазной поверхности, связанные с татуажем век и наращиванием ресниц. Клинические примеры. Офтальмология. 2019;16(3):386–392. doi: 10.18008/1816-5095-2019-3-386-392.</mixed-citation><mixed-citation xml:lang="en">Trubilin VN, Poluninа EG, Andzhelova DV, Kapkova SG, Kurenkov VV, Chinenova KV. Diseases of the Ocular Surface Associated with Eyelid Makeup and Eyelash Extensions. Clinical Examples. Ophthalmology in Russia. 2019;16(3):386–392 (In Russ.). doi: 10.18008/1816-5095-2019-3-386-392.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kato H, Yokoi N, Watanabe A, Komuro A, Sonomura Y, Sotozono C, Kinoshita S. Clinical Factorsfor Determining the Severity of Lid Wiper Epitheliopathy in Dry Eye. Cornea. 2022 May 1;41(5):545–551. doi: 10.1097/ICO.0000000000002879. PMID: 34690267.</mixed-citation><mixed-citation xml:lang="en">Kato H, Yokoi N, Watanabe A, Komuro A, Sonomura Y, Sotozono C, Kinoshita S. Clinical Factorsfor Determining the Severity of Lid Wiper Epitheliopathy in Dry Eye. Cornea. 2022 May 1;41(5):545–551. doi: 10.1097/ICO.0000000000002879. PMID: 34690267.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shi WY. Concerns on the diagnosis and treatment of corneal epitheliopathy. Zhonghua Yan Ke Za Zhi. 2017 Mar 11;53(3):161–163. Chinese. doi: 10.3760/cma.j.is-sn.0412-4081.2017.03.001. PMID: 28316188.</mixed-citation><mixed-citation xml:lang="en">Shi WY. Concerns on the diagnosis and treatment of corneal epitheliopathy. Zhonghua Yan Ke Za Zhi. 2017 Mar 11;53(3):161–163. Chinese. doi: 10.3760/cma.j.is-sn.0412-4081.2017.03.001. PMID: 28316188.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dua HS, Said DG, Messmer EM, Rolando M, BenitezDelCastillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Neurotrophic keratopathy. Prog Retin Eye Res. 2018 Sep;66:107–131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23. PMID: 29698813.</mixed-citation><mixed-citation xml:lang="en">Dua HS, Said DG, Messmer EM, Rolando M, BenitezDelCastillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Neurotrophic keratopathy. Prog Retin Eye Res. 2018 Sep;66:107–131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23. PMID: 29698813.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003 May;76(5):521–542. doi: 10.1016/s0014-4835(03)00050-2. Erratum in: Exp Eye Res. 2003 Aug;77(2):253. PMID: 12697417.</mixed-citation><mixed-citation xml:lang="en">Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003 May;76(5):521–542. doi: 10.1016/s0014-4835(03)00050-2. Erratum in: Exp Eye Res. 2003 Aug;77(2):253. PMID: 12697417.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Labetoulle M, Baudouin C, Calonge M, MerayoLloves J, Boboridis KG, Akova YA, Aragona P, Geerling G, Messmer EM, BenítezDelCastillo J. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019 Mar;97(2):137– 145. doi: 10.1111/aos.13844. Epub 2018 Sep 17. PMID: 30225941.</mixed-citation><mixed-citation xml:lang="en">Labetoulle M, Baudouin C, Calonge M, MerayoLloves J, Boboridis KG, Akova YA, Aragona P, Geerling G, Messmer EM, BenítezDelCastillo J. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019 Mar;97(2):137– 145. doi: 10.1111/aos.13844. Epub 2018 Sep 17. PMID: 30225941.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A, Pagano L, Borgia A. OcularSurface Regeneration Therapies for Eye Disorders: The State of the Art. BioTech (Basel). 2023 Jun 15;12(2):48. doi: 10.3390/biotech12020048. PMID: 37366796; PMCID: PMC10295950.</mixed-citation><mixed-citation xml:lang="en">Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A, Pagano L, Borgia A. OcularSurface Regeneration Therapies for Eye Disorders: The State of the Art. BioTech (Basel). 2023 Jun 15;12(2):48. doi: 10.3390/biotech12020048. PMID: 37366796; PMCID: PMC10295950.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vereertbrugghen A, Pizzano M, Sabbione F, Keitelman IA, Shiromizu CM, Aguilar DV, Fuentes F, de Paiva CS, Giordano M, Trevani A, Galletti JG. An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflammation. 2023 May 22;20(1):120. doi: 10.1186/s12974-023-02800-2. PMID: 37217914; PMCID: PMC10201717.</mixed-citation><mixed-citation xml:lang="en">Vereertbrugghen A, Pizzano M, Sabbione F, Keitelman IA, Shiromizu CM, Aguilar DV, Fuentes F, de Paiva CS, Giordano M, Trevani A, Galletti JG. An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflammation. 2023 May 22;20(1):120. doi: 10.1186/s12974-023-02800-2. PMID: 37217914; PMCID: PMC10201717.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Каспарова ЕА, Марченко НР, Сурнина ЗВ, Митичкина ТС. Возможности конфокальной микроскопии в диагностике акантамебного кератита. Вестник офтальмологии. 2021;137(5-2):201–208. doi: 10.17116/oftalma2021137052201.</mixed-citation><mixed-citation xml:lang="en">Kasparova EA, Marchenko NR, Surnina ZV, Mitichkina TS. Confocal microscopy in the diagnosis of acanthamoeba keratitis. Russian Annals of Ophthalmology. 2021;137(52):201–208 (In Russ.). doi: 10.17116/oftalma2021137052201.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Поздеева НА, Доментьева ЛН, Васильева АЮ, Овчинникова ВН. Применение аутологичной сыворотки при заболеваниях глазной поверхности. Практическая медицина. 2014;1 (77):111–115.</mixed-citation><mixed-citation xml:lang="en">Pozdeyeva NA, Domentyeva LN, Vasilyeva AYu, Ovchinnikova VN. Using the autologous serum in ocular surface diseases. Practical medicine, 2014;1(77):111–115 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Каспаров АА, Каспарова ЕвгА, Фадеева ЛЛ, Суббот АМ, Бородина НВ, Каспарова ЕА, Кобзова МВ, Мусаева ГМ, Павлюк АС. Персонализированная клеточная терапия ранней буллезной кератопатии (экспериментальное обоснование и клинические результаты). Вестник офтальмологии. 2013;129(5):53–61.</mixed-citation><mixed-citation xml:lang="en">Kasparov AA, Kasparova EvgA, Fadeeva LL, Subbot AM, Borodina NV, Kasparova EA, Kobzova MV, Musaeva G, Pavliuk AS. Personalized cell therapy for early postoperative bullous keratopathy (experimental proof and clinical results). Russian Annals of Ophthalmology. 2013;129(5):53–61 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Петрачков ДВ, Алхарки Л, Матющенко АГ, Филиппов ВМ, Дудиева ФК. Сравнение ранних результатов лечения больших сквозных макулярных разрывов при использовании различных хирургических методик. Офтальмология. 2021;18(3S):681–687. doi: 10.18008/1816-5095-2021-3S-681-687.</mixed-citation><mixed-citation xml:lang="en">Petrachkov DV, Alkharki L, Matyushchenko AG, Filippov VM, Dudieva FK. Comparison of Early Treatment Outcomes for Large Macular Hole Using Various Surgical Techniques. Ophthalmology in Russia. 2021;18(3S):681–687 (In Russ.).. doi: 10.18008/1816-5095-2021-3S-681-687.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Боровкова НВ, Филатова ИА, Ченцова ЕВ, Федосеева ЕВ, Павленко ЮА, Шеметов СА, Петрова АО, Пономарев ИН. Эффективность применения лизата богатой тромбоцитами плазмы (БоТП) у пациентов с эрозией роговицы или посттравматическим рубцеванием тканей век. Российский офтальмологический журнал. 2020;13(3):8–14. doi: 10.21516/2072-0076-2020-13-3-8-14.</mixed-citation><mixed-citation xml:lang="en">Borovkova NV, Filatova IA, Chentsova EV, Fedoseeva EV, Pavlenko YuA, Ponomarev IN, Shemetov SA, Petrova AO. Efficacy of plateletrich plasma lysate in patients with corneal erosion or posttraumatic scarring of the tissues of the eyelids. Russian Ophthalmological Journal. 2020;13(3):8–14 (In Russ.). doi: 10.21516/2072-0076-2020-13-3-8-14.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous SerumBased Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 Jan;127(1):128–133. doi: 10.1016/j.ophtha.2019.08.018. Epub 2019 Sep 24. PMID: 31561880.</mixed-citation><mixed-citation xml:lang="en">Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous SerumBased Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 Jan;127(1):128–133. doi: 10.1016/j.ophtha.2019.08.018. Epub 2019 Sep 24. PMID: 31561880.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Roumeau S, Dutheil F, Sapin V, Baker JS, Watson SL, Pereira B, Chiambaretta F, Navel V. Efficacy of treatments for neurotrophic keratopathy: a systematic review and metaanalysis. Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623–2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7. PMID: 35254511.</mixed-citation><mixed-citation xml:lang="en">Roumeau S, Dutheil F, Sapin V, Baker JS, Watson SL, Pereira B, Chiambaretta F, Navel V. Efficacy of treatments for neurotrophic keratopathy: a systematic review and metaanalysis. Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623–2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7. PMID: 35254511.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Semeraro F, Forbice E, Braga O, Bova A, Di Salvatore A, Azzolini C. Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int. 2014;2014:826970. doi: 10.1155/2014/826970. Epub 2014 Jul 22. PMID: 25136628; PMCID: PMC4130192.</mixed-citation><mixed-citation xml:lang="en">Semeraro F, Forbice E, Braga O, Bova A, Di Salvatore A, Azzolini C. Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int. 2014;2014:826970. doi: 10.1155/2014/826970. Epub 2014 Jul 22. PMID: 25136628; PMCID: PMC4130192.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Weischnur L, Xanthopoulou K, Munteanu C, Leonhard M, Daas L, Seitz B. Autologe Serumaugentropfen bei therapieresistenten Epitheldefekten der Kornea : Einfluss der Grunderkrankung und einer simultanen Amnionmembrantransplantation bei 990 Anwendungen [Autologous serum eye drops for therapyresistant epithelial defects of the cornea: Impact of underlying disease and simultaneous amniotic transplantation in 990 applications]. Ophthalmologie. 2023 Jan;120(1):43–51. German. doi: 10.1007/s00347-022-01677-5. Epub 2022 Jun 23. PMID: 35925344.</mixed-citation><mixed-citation xml:lang="en">Weischnur L, Xanthopoulou K, Munteanu C, Leonhard M, Daas L, Seitz B. Autologe Serumaugentropfen bei therapieresistenten Epitheldefekten der Kornea : Einfluss der Grunderkrankung und einer simultanen Amnionmembrantransplantation bei 990 Anwendungen [Autologous serum eye drops for therapyresistant epithelial defects of the cornea: Impact of underlying disease and simultaneous amniotic transplantation in 990 applications]. Ophthalmologie. 2023 Jan;120(1):43–51. German. doi: 10.1007/s00347-022-01677-5. Epub 2022 Jun 23. PMID: 35925344.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Vazirani J, Sridhar U, Gokhale N, Doddigarla VR, Sharma S, Basu S. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines. Indian J Ophthalmol. 2023 Apr;71(4):1357–1363. doi: 10.4103/IJO.IJO_2756_22. PMID: 37026267; PMCID: PMC10276663.</mixed-citation><mixed-citation xml:lang="en">Vazirani J, Sridhar U, Gokhale N, Doddigarla VR, Sharma S, Basu S. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines. Indian J Ophthalmol. 2023 Apr;71(4):1357–1363. doi: 10.4103/IJO.IJO_2756_22. PMID: 37026267; PMCID: PMC10276663.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal S, Colon C, Kheirkhah A, Hamrah P. Efficacy of autologous serum tears for treatment of neuropathic corneal pain. Ocul Surf. 2019 Jul;17(3):532–539. doi: 10.1016/j.jtos.2019.01.009. Epub 2019 Jan 24. PMID: 30685437; PMCID: PMC6956846.</mixed-citation><mixed-citation xml:lang="en">Aggarwal S, Colon C, Kheirkhah A, Hamrah P. Efficacy of autologous serum tears for treatment of neuropathic corneal pain. Ocul Surf. 2019 Jul;17(3):532–539. doi: 10.1016/j.jtos.2019.01.009. Epub 2019 Jan 24. PMID: 30685437; PMCID: PMC6956846.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Stenwall PA, Bergström M, Seiron P, Sellberg F, Olsson T, Knutson F, Berglund D. Improving the antiinflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction. Acta Ophthalmol. 2015 Nov;93(7):654– 657. doi: 10.1111/aos.12801. Epub 2015 Jul 14. PMID: 26178796.</mixed-citation><mixed-citation xml:lang="en">Stenwall PA, Bergström M, Seiron P, Sellberg F, Olsson T, Knutson F, Berglund D. Improving the antiinflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction. Acta Ophthalmol. 2015 Nov;93(7):654– 657. doi: 10.1111/aos.12801. Epub 2015 Jul 14. PMID: 26178796.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012 Aug;37(6):652– 657. doi: 10.1111/j.1365-2230.2011.04303.x. Epub 2012 Feb 14. PMID: 22329713.</mixed-citation><mixed-citation xml:lang="en">Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012 Aug;37(6):652– 657. doi: 10.1111/j.1365-2230.2011.04303.x. Epub 2012 Feb 14. PMID: 22329713.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wu MF, Stachon T, Seitz B, Langenbucher A, Szentmáry N. Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro. Int J Ophthalmol. 2017 Jun 18;10(6):908–913. doi: 10.18240/ijo.2017.06.12. PMID: 28730081; PMCID: PMC5515161.</mixed-citation><mixed-citation xml:lang="en">Wu MF, Stachon T, Seitz B, Langenbucher A, Szentmáry N. Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro. Int J Ophthalmol. 2017 Jun 18;10(6):908–913. doi: 10.18240/ijo.2017.06.12. PMID: 28730081; PMCID: PMC5515161.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol. 2008 NovDec;71(6 Suppl):47–54. PMID: 19274411.</mixed-citation><mixed-citation xml:lang="en">Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol. 2008 NovDec;71(6 Suppl):47–54. PMID: 19274411.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004 Nov;88(11):1467–474. doi: 10.1136/bjo.2004.044347. PMID: 15489495; PMCID: PMC1772389.</mixed-citation><mixed-citation xml:lang="en">Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004 Nov;88(11):1467–474. doi: 10.1136/bjo.2004.044347. PMID: 15489495; PMCID: PMC1772389.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">CabreraAguas M, Khoo P, Watson SL. Infectious keratitis: A review. Clin Exp Ophthalmol. 2022 Jul;50(5):543–562. doi: 10.1111/ceo.14113. Epub 2022 Jun 3. PMID: 35610943; PMCID: PMC9542356.</mixed-citation><mixed-citation xml:lang="en">CabreraAguas M, Khoo P, Watson SL. Infectious keratitis: A review. Clin Exp Ophthalmol. 2022 Jul;50(5):543–562. doi: 10.1111/ceo.14113. Epub 2022 Jun 3. PMID: 35610943; PMCID: PMC9542356.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Amano Y, Sugimoto Y, Sugita M. Ocular disorders due to eyelash extensions. Cornea. 2012 Feb;31(2):121–125. doi: 10.1097/ICO.0b013e31821eea10. PMID: 22134404.</mixed-citation><mixed-citation xml:lang="en">Amano Y, Sugimoto Y, Sugita M. Ocular disorders due to eyelash extensions. Cornea. 2012 Feb;31(2):121–125. doi: 10.1097/ICO.0b013e31821eea10. PMID: 22134404.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
